501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro

por Liu, Haolin, Wei, Pengcheng, Zhang, Qianqian, Chen, Zhongzhou, Aviszus, Katja, Downing, Walter, Peterson, Shelley, Reynoso, Lyndon, Downey, Gregory P., Frankel, Stephen K., Kappler, John, Marrack, Philippa, Zhang, Gongyi
Publicado 2021

The basis of a more contagious 501Y.V1 variant of SARS-CoV-2

por Liu, Haolin, Zhang, Qianqian, Wei, Pengcheng, Chen, Zhongzhou, Aviszus, Katja, Yang, John, Downing, Walter, Jiang, Chengyu, Liang, Bo, Reynoso, Lyndon, Downey, Gregory P., Frankel, Stephen K., Kappler, John, Marrack, Philippa, Zhang, Gongyi
Publicado 2021

The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines

por Liu, Haolin, Wei, Pengcheng, Zhang, Qianqian, Aviszus, Katja, Linderberger, Jared, Yang, John, Liu, Junfeng, Chen, Zhongzhou, Waheed, Hassan, Reynoso, Lyndon, Downey, Gregory P., Frankel, Stephen K., Kappler, John, Marrack, Philippa, Zhang, Gongyi
Publicado 2021

The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity

por Liu, Haolin, Wei, Pengcheng, Aviszus, Katja, Zhang, Qianqian, Linderberger, Jared, Yang, John, Liu, Junfeng, Chen, Zhongzhou, Waheed, Hassan, Reynoso, Lyndon, Downey, Gregory P., Frankel, Stephen K., Kappler, John W., Marrack, Philippa, Zhang, Gongyi
Publicado 2022